Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phio Pharmaceuticals (PHIO) Research & Development (2016 - 2021)

Phio Pharmaceuticals' Research & Development history spans 10 years, with the latest figure at $2.2 million for Q4 2021.

  • For Q4 2021, Research & Development rose 380.56% year-over-year to $2.2 million; the TTM value through Dec 2021 reached $8.9 million, up 139.13%, while the annual FY2024 figure was $3.6 million, 42.47% down from the prior year.
  • Research & Development reached $2.2 million in Q4 2021 per PHIO's latest filing, down from $2.7 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $2.7 million in Q3 2021 to a low of $463000.0 in Q4 2020.
  • Average Research & Development over 5 years is $1.3 million, with a median of $1.2 million recorded in 2017.
  • Peak YoY movement for Research & Development: tumbled 54.74% in 2020, then skyrocketed 380.56% in 2021.
  • A 5-year view of Research & Development shows it stood at $1.2 million in 2017, then decreased by 21.59% to $944000.0 in 2018, then grew by 8.37% to $1.0 million in 2019, then crashed by 54.74% to $463000.0 in 2020, then surged by 380.56% to $2.2 million in 2021.
  • Per Business Quant, the three most recent readings for PHIO's Research & Development are $2.2 million (Q4 2021), $2.7 million (Q3 2021), and $1.6 million (Q2 2021).